The antibiotic resistance crisis has a farm problem — and clinicians have more power than they think

Every clinician who has faced a resistant organism knows the antibiotic toolkit is shrinking. But most of that resistance isn't originating in hospitals — it's coming from farms. In the U.S., roughly 70% of medically important antibiotics are sold for use in food animals, and the majority isn't treating sick livestock. It's keeping healthy animals alive in the densely packed conditions that industrial meat production requires.

The scale of the problem is staggering, and it's growing. Global livestock antibiotic use is projected to rise by nearly a third by 2040. The colistin story offers a rare proof point: when China banned the drug as a feed additive in 2017, resistance levels fell — in animals and in people. It's a real-world example showing that upstream policy changes can restore clinical utility to drugs we'd nearly lost.

By the Numbers:

• ~70% of medically important U.S. antibiotics are sold for food-animal use
• ~35,000 Americans die annually from drug-resistant infections
• ~39 million projected global deaths from resistant infections by 2050
• Livestock antibiotic use projected to rise ~33% by 2040

Why it matters: Stewardship programs focused only on clinical prescribing are tackling a downstream symptom. Clinicians can act now — by counseling patients toward plant-forward diets, pushing professional societies to advocate for farm-level antibiotic reform, and raising institutional food-purchasing decisions on stewardship committee agendas.